Literature DB >> 21165712

Mood disorders and obesity: understanding inflammation as a pathophysiological nexus.

Joanna K Soczynska1, Sidney H Kennedy, Hanna O Woldeyohannes, Samantha S Liauw, Mohammad Alsuwaidan, Christina Y Yim, Roger S McIntyre.   

Abstract

The aim of this review is to evaluate the evidentiary base supporting the hypothesis that the increased hazard for obesity in mood disorder populations (and vice versa) is a consequence of shared pathophysiological pathways. We conducted a PubMed search of all English-language articles with the following search terms: obesity, inflammation, hypothalamic-pituitary-adrenal axis, insulin, cognition, CNS, and neurotransmitters, cross-referenced with major depressive disorder and bipolar disorder. The frequent co-occurrence of mood disorders and obesity may be characterized by interconnected pathophysiology. Both conditions are marked by structural and functional abnormalities in multiple cortical and subcortical brain regions that subserve cognitive and/or affective processing. Abnormalities in several interacting biological networks (e.g. immuno-inflammatory, insulin signaling, and counterregulatory hormones) contribute to the co-occurence of mood disorders and obesity. Unequivocal evidence now indicates that obesity and mood disorders are chronic low-grade pro-inflammatory states that result in a gradual accumulation of allostatic load. Abnormalities in key effector proteins of the pro-inflammatory cascade include, but are not limited to, cytokines/adipokines such as adiponectin, leptin, and resistin as well as tumor necrosis factor alpha and interleukin-6. Taken together, the bidirectional relationship between obesity and mood disorders may represent an exophenotypic manifestation of aberrant neural and inflammatory networks. The clinical implications of these observations are that, practitioners should screen individuals with obesity for the presence of clinically significant depressive symptoms (and vice versa). This clinical recommendation is amplified in individuals presenting with biochemical indicators of insulin resistance and other concurrent conditions associated with abnormal inflammatory signaling (e.g. cardiovascular disease).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21165712     DOI: 10.1007/s12017-010-8140-8

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  230 in total

1.  Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface.

Authors:  Andrew H Miller
Journal:  Brain Behav Immun       Date:  2008-09-03       Impact factor: 7.217

2.  Dopaminergic agonists normalize elevated hypothalamic neuropeptide Y and corticotropin-releasing hormone, body weight gain, and hyperglycemia in ob/ob mice.

Authors:  K G Bina; A H Cincotta
Journal:  Neuroendocrinology       Date:  2000-01       Impact factor: 4.914

3.  Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study.

Authors:  Rachel A Whitmer; Erica P Gunderson; Elizabeth Barrett-Connor; Charles P Quesenberry; Kristine Yaffe
Journal:  BMJ       Date:  2005-04-29

4.  Prevalence of overweight and obesity in the United States, 1999-2004.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal
Journal:  JAMA       Date:  2006-04-05       Impact factor: 56.272

5.  Glucocorticoids as counterregulatory hormones of leptin: toward an understanding of leptin resistance.

Authors:  K E Zakrzewska; I Cusin; A Sainsbury; F Rohner-Jeanrenaud; B Jeanrenaud
Journal:  Diabetes       Date:  1997-04       Impact factor: 9.461

6.  Reduced production of interferon-gamma but not interleukin-10 in bipolar mania and subsequent remission.

Authors:  Kuan-Pin Su; Sy-Jye C Leu; Yi-Yuan Yang; Winston W Shen; Yech-Mei Chou; Shang-Ying M Tsai
Journal:  J Affect Disord       Date:  2002-09       Impact factor: 4.839

7.  Individual differences in reinforcement learning: behavioral, electrophysiological, and neuroimaging correlates.

Authors:  Diane L Santesso; Daniel G Dillon; Jeffrey L Birk; Avram J Holmes; Elena Goetz; Ryan Bogdan; Diego A Pizzagalli
Journal:  Neuroimage       Date:  2008-07-02       Impact factor: 6.556

Review 8.  Gliogenesis and glial pathology in depression.

Authors:  G Rajkowska; J J Miguel-Hidalgo
Journal:  CNS Neurol Disord Drug Targets       Date:  2007-06       Impact factor: 4.388

Review 9.  Inflammatory pathways and insulin action.

Authors:  G S Hotamisligil
Journal:  Int J Obes Relat Metab Disord       Date:  2003-12

10.  Extra-adrenal regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioning.

Authors:  Brian R Walker
Journal:  Proc Nutr Soc       Date:  2007-02       Impact factor: 6.297

View more
  38 in total

1.  What is the Importance of Body Composition in Obesity-related Depression?

Authors:  Ulkuhan Iner Koksal; Zeynep Erturk; Ali Riza Koksal; Ekmel Burak Ozsenel; Ozlem Harmankaya Kaptanogullari
Journal:  Eurasian J Med       Date:  2017-04-28

2.  Differential Impact of Obesity on CD69 Expression in Individuals with Bipolar Disorder and Healthy Controls.

Authors:  Ana S Yamagata; Lucas B Rizzo; Raphael O Cerqueira; Janine Scott; Quirino Cordeiro; Roger S McIntyre; Rodrigo B Mansur; Elisa Brietzke
Journal:  Mol Neuropsychiatry       Date:  2018-02-01

3.  Hypothalamic stimulation enhances hippocampal BDNF plasticity in proportion to metabolic rate.

Authors:  Zhe Ying; Alejandro Covalin; Jack Judy; Fernando Gomez-Pinilla
Journal:  Brain Stimul       Date:  2012-02-22       Impact factor: 8.955

Review 4.  Mood disorders: A potential link between ghrelin and leptin on human body?

Authors:  Stalo Zarouna; Greta Wozniak; Anastasia Ioannis Papachristou
Journal:  World J Exp Med       Date:  2015-05-20

Review 5.  Bipolar disorder: role of immune-inflammatory cytokines, oxidative and nitrosative stress and tryptophan catabolites.

Authors:  George Anderson; Michael Maes
Journal:  Curr Psychiatry Rep       Date:  2015-02       Impact factor: 5.285

6.  Brain and behavioral correlates of insulin resistance in youth with depression and obesity.

Authors:  Manpreet K Singh; Sara M Leslie; Mary Melissa Packer; Yevgeniya V Zaiko; Owen R Phillips; Elizabeth F Weisman; Danielle M Wall; Booil Jo; Natalie Rasgon
Journal:  Horm Behav       Date:  2018-04-23       Impact factor: 3.587

7.  Methylphenidate prevents high-fat diet (HFD)-induced learning/memory impairment in juvenile mice.

Authors:  Melissa M Kaczmarczyk; Agnieszka S Machaj; Gabriel S Chiu; Marcus A Lawson; Stephen J Gainey; Jason M York; Daryl D Meling; Stephen A Martin; Kristin A Kwakwa; Andrew F Newman; Jeffrey A Woods; Keith W Kelley; Yanyan Wang; Michael J Miller; Gregory G Freund
Journal:  Psychoneuroendocrinology       Date:  2013-02-11       Impact factor: 4.905

8.  The neurotherapeutic role of a selenium-functionalized quinoline in hypothalamic obese rats.

Authors:  Ethel Antunes Wilhelm; Cristiane Luchese; Karline C Rodrigues; Cristiani F Bortolatto; Ketlyn P da Motta; Renata L de Oliveira; Jaini J Paltian; Roberta Krüger; Silvane S Roman; Silvana P Boeira; Diego Alves
Journal:  Psychopharmacology (Berl)       Date:  2021-03-19       Impact factor: 4.530

Review 9.  Bypassing TBI: Metabolic Surgery and the Link between Obesity and Traumatic Brain Injury-a Review.

Authors:  T W McGlennon; J N Buchwald; Walter J Pories; Fang Yu; Arthur Roberts; Eric P Ahnfeldt; Rukmini Menon; Henry Buchwald
Journal:  Obes Surg       Date:  2020-10-30       Impact factor: 4.129

10.  Acute psychological stress results in the rapid development of insulin resistance.

Authors:  Li Li; Xiaohua Li; Wenjun Zhou; Joseph L Messina
Journal:  J Endocrinol       Date:  2013-04-15       Impact factor: 4.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.